Nama Insights

ARK Genomic Revolution ETF (ARKG)

Health · ARK ETF Trust · BATS

HealthETF
ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund in the Health category. It has $2.21B in assets, an expense ratio of 0.75% and a 0.00% dividend yield. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
Assets under management$2.21B
Expense ratio0.75%
CategoryHealth
Dividend yield0.00%
NAV$43.15
Fund familyARK ETF Trust
ExchangeBATS

Top holdings

The largest positions ARK Genomic Revolution ETF reports, by weight.

HoldingNameWeight
TWST Twist Bioscience Corp 8.75%
TXG 10x Genomics Inc Ordinary Shares - Class A 8.73%
TEM Tempus AI Inc Class A common stock 8.36%
ABSI Absci Corp 5.56%
CRSP CRISPR Therapeutics AG 5.22%
GH Guardant Health Inc 4.88%
NTRA Natera Inc 4.71%
ILMN Illumina Inc 4.69%
LLY Eli Lilly and Co 3.92%
BEAM Beam Therapeutics Inc 3.69%

Other Health ETFs

Explore live ARKG data on Nama Insights →